학술논문
Low Dose Decitabine Versus Best Supportive Care in Elderly Patients with Intermediate or High Risk MDS Not Eligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study (06011) of the EORTC Leukemia and German MDS Study Groups
Document Type
Abstract
Author
Source
In Blood 16 November 2008 112(11):226-226
Subject
Language
ISSN
0006-4971